1. Lane SW, Scadden DT, Gilliland DG. The leukemic stem cell niche: current concepts and therapeutic opportunities. Blood. 2009;114:1150.
2. Jordan CT. Unique molecular and cellular features of acute myelogenous leukemia stem cells. Leukemia. 2002;16:559.
3. Paietta E. Phenotypic correlates of genetic abnormalities in acute and chronic leukemias. In: Detrick B, Hamilton RG, Folds JD, editors. Manual of molecular and clinical laboratory immunology. 7th ed. Washington, DC: ASM Press; 2006. p. 201.
4. Paietta E. Surrogate marker profiles for genetic lesions in acute leukemias. In Paietta E, editor. Bailliere’s best practice & research: clinical haematology, immunophenotyping in haematologic malignancies: state of the art, Elsevier, Amsterdam, Netherlands, vol. 23. 2010;p. 359–68.
5. American Cancer Society: Atlas of clinical oncology series volume, Wiernik PH (series ed.);E Paietta,2001